Hemlibra Prices, Coupons and Patient Assistance Programs
Hemlibra (emicizumab) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A and Hemophilia A with Inhibitors.
Hemlibra Prices
This Hemlibra price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Hemlibra subcutaneous solution (30 mg/mL) is around $3,148 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Subcutaneous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 1 milliliter(s) | $3,147.59 | $3,147.59 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
| Quantity | Per unit | Price |
|---|---|---|
| 1 milliliter(s) | $15,699.94 | $15,699.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Hemlibra Coupons and Rebates
Hemlibra offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Hemlibra Co-pay Program: Eligible patients may pay $5 per copay or co-insurance with savings of up to $15,000 per 12-month period; for additional information contact the program at 844-436-2672.
| Applies to: | Hemlibra |
| Number of uses: | 12 times |
Patient Assistance Programs for Hemlibra
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Hemlibra (emicizumab) Injection; Subcutaneous
Provider: Genentech Patient Foundation
Elligibility requirements:
- Uninsured or Underinsured with no prescription coverage for needed medication
- Income Guidelines published on Program Website
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Hemlibra (emicizumab) Injection; Subcutaneous
Provider: Genentech Access Solutions (Hemlibra)
Elligibility requirements:
- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
- Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
- Hemlibra (emicizumab) Injection; Subcutaneous
More about Hemlibra (emicizumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: miscellaneous coagulation modifiers
- FDA Approval History
